Estonia’s top diplomat thinks Russia’s war on Ukraine goes well beyond the front lines. “This …
Read More »FDA approves first medication for obstructive sleep apnea, promotes weight loss
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to …
Read More »